Large-Scale Profiling of Extracellular Vesicles Identified miR-625-5p as a Novel Biomarker of Immunotherapy Response in Advanced Non-Small-Cell Lung Cancer Patients.
Saved in:
| Title: | Large-Scale Profiling of Extracellular Vesicles Identified miR-625-5p as a Novel Biomarker of Immunotherapy Response in Advanced Non-Small-Cell Lung Cancer Patients. |
|---|---|
| Authors: | Pantano F; Medical Oncology Department, Campus Bio-Medico University of Rome, 00128 Rome, Italy., Zalfa F; Pathology Department, Campus Bio-Medico University, 00128 Rome, Italy., Iuliani M; Medical Oncology Department, Campus Bio-Medico University of Rome, 00128 Rome, Italy., Simonetti S; Medical Oncology Department, Campus Bio-Medico University of Rome, 00128 Rome, Italy., Manca P; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy., Napolitano A; Medical Oncology Department, Campus Bio-Medico University of Rome, 00128 Rome, Italy., Tiberi S; Department of Molecular Life Sciences and Swiss Institute of Bioinformatics, University of Zurich, Winterthurerstrasse 190, 8057 Zurich, Switzerland., Russano M; Medical Oncology Department, Campus Bio-Medico University of Rome, 00128 Rome, Italy., Citarella F; Medical Oncology Department, Campus Bio-Medico University of Rome, 00128 Rome, Italy., Foderaro S; Medical Oncology Department, Campus Bio-Medico University of Rome, 00128 Rome, Italy., Vulpis E; Laboratory Affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Department of Molecular Medicine, Sapienza University of Rome, 00161 Rome, Italy., Zingoni A; Laboratory Affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Department of Molecular Medicine, Sapienza University of Rome, 00161 Rome, Italy., Masuelli L; Department of Experimental Medicine, Sapienza University of Rome, 00161 Rome, Italy., Bei R; Department of Clinical Sciences and Translational Medicine, University of Rome 'Tor Vergata', 00133 Rome, Italy., Ribelli G; Medical Oncology Department, Campus Bio-Medico University of Rome, 00128 Rome, Italy., Del Re M; Unit of Clinical Pharmacology and Pharmacogenetics, Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy., Danesi R; Unit of Clinical Pharmacology and Pharmacogenetics, Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy., Vincenzi B; Medical Oncology Department, Campus Bio-Medico University of Rome, 00128 Rome, Italy., Perrone G; Pathology Department, Campus Bio-Medico University, 00128 Rome, Italy., Tonini G; Medical Oncology Department, Campus Bio-Medico University of Rome, 00128 Rome, Italy., Santini D; Medical Oncology Department, Campus Bio-Medico University of Rome, 00128 Rome, Italy.; UOC of Oncology-ASL Latina-Distretto 1, University of Rome 'Sapienza', 04011 Aprilia, Italy . |
| Source: | Cancers [Cancers (Basel)] 2022 May 14; Vol. 14 (10). Date of Electronic Publication: 2022 May 14. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2072-6694 |
|---|---|
| DOI: | 10.3390/cancers14102435 |
